Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder - Reuters
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxQRFJWek5pTm92Nm0xVUNQWWlNRDZZaVktb1JBOHhCSlEzOEJoUXZBakRwSF9TeXpualljSVR6RThqeEFOQ29yYzZ5NTYwQmdSQlVYSTFOdWNfZm1yT1VGMldWR0xzaDVsQzVGS3YxZjBUVFQyMEt1aDJlQ000WG1rZGVJTmpaNnRocmh5RFBvYjI1ek5XRkNxczM2WjZGckVTQ01henNGdWJSVHhZTGxIcXJsa0k4bGZ0UWtNbVdNRlhMQlliQ0dRWE9qU1VURWwxTlhfaFdR?oc=5" target="_blank">Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Teva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMAlector soars as Roche licenses Parkinson's therapy for up to $1.27 billion - Reuters
Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion Reuters
October 5, 2026 at 12:15 PMCSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis - Reuters
CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis Reuters
October 4, 2026 at 10:18 PMNovartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026 at 10:57 AMUS FDA approves Mirum's drug for rare bone disorder - reuters.com
US FDA approves Mirum's drug for rare bone disorder reuters.com
September 25, 2026 at 08:11 PMChina's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion - Reuters
China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion Reuters
September 24, 2026 at 04:55 AM